platelet derived growth factor receptor beta (Cell Signaling Technology Inc)
Structured Review

Platelet Derived Growth Factor Receptor Beta, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 558 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+derived+growth+factor+receptor+beta/bio_rxiv__64898__2026__03__09__710504-69-15-21?v=Cell+Signaling+Technology+Inc
Average 96 stars, based on 558 article reviews
Images
1) Product Images from "Multimodality Molecular Profiling Nominates Targetable Mechanisms in Progressive RV Dysfunction"
Article Title: Multimodality Molecular Profiling Nominates Targetable Mechanisms in Progressive RV Dysfunction
Journal: bioRxiv
doi: 10.64898/2026.03.09.710504
Figure Legend Snippet: RV endothelial and pericyte abundances and colocalization patterns were associated with cardiomyocyte hypoxia signaling and with progressive RV compromise. (A) UMAP visualizing endothelial cells and pericytes in snRNAseq data. (B) Endothelial cell and (C) pericyte relative abundances were similar between mild RVD and control, but elevated in severe RVD. (D) Representative image of RV sections stained with isolectin B4 (IB4) showing capillary density is higher in severe RVD (white arrows: capillaries, yellow: WGA, purple: IB4), quantified as (E) the percent area occupied by endothelial cells. (F) Representative image of RV sections stained with IB4 and platelet derived growth factor receptor beta (PDGFRβ) to mark endothelial cells and pericytes, respectively. Endothelial cell-pericyte localization was altered in severe RVD (white arrows: co-localized endothelial cells and pericytes, red arrow: pericytes not located near endothelial cells, orange: IB4, blue: PDGFRβ) quantified with a colocalization coefficient. (H) Cardiomyocyte HIF1A expression was highest in severe RVD. One way ANOVA with Tukey’s post-hoc, means shown in B-C, E, G.
Techniques Used: Control, Staining, Derivative Assay, Expressing
